S100A10 and prostate cancer: In our study, for the first time, we have identified increased expression of SCARB1 and MAPK3K1 and decreased expression of S100A10 in PCAFs compared to PNAFs even if the role of these genes in prostate cancer progression and androgen resistance is well known.